Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

17.06.2024

2 Antiviral Res
16 BMJ
2 J Clin Microbiol
1 J Epidemiol Community Health
9 J Infect Dis
5 J Virol
2 JAMA
8 Lancet
3 N Engl J Med
2 PLoS Comput Biol
28 PLoS One
3 Proc Natl Acad Sci U S A
5 Vaccine
2 Virology


    Antiviral Res

  1. ZHAI G, Fu W, Yuan S, Sun P, et al
    A fusion protein approach to integrate antiviral and anti-inflammatory activities for developing new therapeutics against influenza A virus infection.
    Antiviral Res. 2024 Jun 9:105924. doi: 10.1016/j.antiviral.2024.105924.
    >> Share

  2. LI J, Cui H, Yao Y, Niu J, et al
    Anti-influenza activity of CPAVM1 protease secreted by Bacillus subtilis LjM2.
    Antiviral Res. 2024 Jun 6:105919. doi: 10.1016/j.antiviral.2024.105919.
    >> Share


    BMJ

  3. MAHASE E
    Bird flu: First person with confirmed H5N2 infection dies.
    BMJ. 2024;385:q1260.
    >> Share

  4. SMITH C
    Infected blood inquiry: justice will only be delivered when all the recommendations are acted upon.
    BMJ. 2024;385:q1256.
    >> Share

  5. VIZE R
    What are the early election promises on health?
    BMJ. 2024;385:q1258.
    >> Share

  6. MAHASE E
    Bird flu: Australia records first human case of H5N1.
    BMJ. 2024;385:q1281.
    >> Share

  7. DEAN E
    Why I . . . make free flight aircraft.
    BMJ. 2024;385:q1157.
    >> Share

  8. KMIETOWICZ Z
    Sixty seconds on . . . flying.
    BMJ. 2024;385:q1266.
    >> Share

  9. TORJESEN I
    Hospital doctors in Wales to vote on enhanced pay deal for 2023-24.
    BMJ. 2024;385:q1273.
    >> Share

  10. MAHASE E
    RCP president is asked to resign over handling of physician associates row.
    BMJ. 2024;385:q1291.
    >> Share

  11. LAL N
    Study on adverse effects following Covaxin stirs heated debate in India.
    BMJ. 2024;385:q1300.
    >> Share

  12. IACOBUCCI G
    Tories pledge to slash number of NHS managers to fund health spending.
    BMJ. 2024;385:q1297.
    >> Share

  13. SADGROVE NEE STACEY C
    Help create an opportunity to learn together.
    BMJ. 2024;385:q868.
    >> Share

  14. SHEPHERD A
    Striking doctors rally in Stormont.
    BMJ. 2024;385:q1280.
    >> Share

  15. MAHASE E
    Bird flu: India reports human case of H9N2 in 4 year old.
    BMJ. 2024;385:q1317.
    >> Share

  16. RIMMER A
    Four year medical degree set to launch in 2026, says NHS England.
    BMJ. 2024;385:q1312.
    >> Share


  17. Seven days in medicine: 5-11 June 2024.
    BMJ. 2024;385:q1278.
    >> Share

  18. KMIETOWICZ Z
    Labour vows to "fix NHS again" after Tories leave it "broken".
    BMJ. 2024;385:q1315.
    >> Share


    J Clin Microbiol

  19. MARGULIS M, Rohana H, Erster O, Mandelboim M, et al
    Highly sensitive extraction-free saliva-based molecular assay for rapid diagnosis of SARS-CoV-2.
    J Clin Microbiol. 2024;62:e0060024.
    >> Share

  20. POWELL EA, Greninger AL, Marlowe EM, Naccache SN, et al
    Proceedings of the Clinical Microbiology Open 2023: discussions about pandemic preparedness.
    J Clin Microbiol. 2024;62:e0014424.
    >> Share


    J Epidemiol Community Health

  21. RHEAD R, Wels J, Moltrecht B, Shaw RJ, et al
    Long COVID and financial outcomes: evidence from four longitudinal population surveys.
    J Epidemiol Community Health. 2024;78:458-465.
    >> Share


    J Infect Dis

  22. ATTUR M, Petrilli C, Adhikari S, Iturrate E, et al
    Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19.
    J Infect Dis. 2024;229:1740-1749.
    >> Share

  23. HARTELOH P, van Mechelen R
    Reply to Mattiuzzi and Lippi.
    J Infect Dis. 2024;229:1930.
    >> Share

  24. MATTIUZZI C, Lippi G
    Historical Comparison Between the Death Rate for Spanish Flu and Coronavirus Disease 2019 in Italy.
    J Infect Dis. 2024;229:1928-1929.
    >> Share

  25. GAY L, Rouviere MS, Mezouar S, Richaud M, et al
    Vgamma9Vdelta2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19.
    J Infect Dis. 2024;229:1759-1769.
    >> Share

  26. IVERSEN KK, Ronit A, Ahlstrom MG, Nordestgaard BG, et al
    Lung Function Trajectories in Mild COVID-19 With 2-year Follow-up.
    J Infect Dis. 2024;229:1750-1758.
    >> Share

  27. CARROLL TD, Wong T, Morris MK, Di Germanio C, et al
    Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.
    J Infect Dis. 2024 Jan 12:jiad568. doi: 10.1093.
    >> Share

  28. ZHANG Y, Zhou Y, Chen J, Wu J, et al
    Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.
    J Infect Dis. 2023 Dec 27:jiad572. doi: 10.1093.
    >> Share

  29. LACOURSE SM, Wetzler EA, Aurelio MC, Escudero JN, et al
    Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone.
    J Infect Dis. 2024;229:1728-1739.
    >> Share

  30. LIM SY, Kim JW, Kim JY, Kang SW, et al
    The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study.
    J Infect Dis. 2024;229:1722-1727.
    >> Share


    J Virol

  31. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    >> Share

  32. CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
    Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6' active site specificity.
    J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
    >> Share

  33. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    >> Share

  34. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    >> Share

  35. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    >> Share


    JAMA

  36. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    >> Share

  37. VAN DER LINDEN S, Roozenbeek J
    "Inoculation" to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    >> Share


    Lancet

  38. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    >> Share

  39. ANIRVAN P
    Blowing in the wind-India's health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    >> Share

  40. MOHAPATRA PR
    Responding to India's data and transparency.
    Lancet. 2024;403:2482-2483.
    >> Share

  41. THE LANCET
    H5N1: international failures and uncomfortable truths.
    Lancet. 2024;403:2455.
    >> Share

  42. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    >> Share

  43. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial - Authors' reply.
    Lancet. 2024;403:2484-2485.
    >> Share

  44. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    >> Share

  45. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    >> Share


    N Engl J Med

  46. KAISER F, Morris DH, Wickenhagen A, Mukesh R, et al
    Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 degrees C and 72 degrees C.
    N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMc2405488.
    >> Share

  47. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts - Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    >> Share

  48. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    >> Share


    PLoS Comput Biol

  49. HILL EM, Petrou S, de Lusignan S, Yonova I, et al
    Correction: Seasonal influenza: Modelling approaches to capture immunity propagation.
    PLoS Comput Biol. 2024;20:e1012213.
    >> Share

  50. RAWSON T, Hinsley W, Sonabend R, Semenova E, et al
    The impact of health inequity on spatial variation of COVID-19 transmission in England.
    PLoS Comput Biol. 2024;20:e1012141.
    >> Share


    PLoS One

  51. AMANI B, Amani B
    Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298772.
    >> Share

  52. KAKEE S, Kanai K, Tsuneki-Tokunaga A, Okuno K, et al
    Difference in TMPRSS2 usage by Delta and Omicron variants of SARS-CoV-2: Implication for a sudden increase among children.
    PLoS One. 2024;19:e0299445.
    >> Share

  53. MORGENSTERN C, Laydon DJ, Whittaker C, Mishra S, et al
    The interaction of disease transmission, mortality, and economic output over the first 2 years of the COVID-19 pandemic.
    PLoS One. 2024;19:e0301785.
    >> Share

  54. BREWER SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, et al
    Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
    PLoS One. 2024;19:e0305160.
    >> Share

  55. CHANG O, Levitt A, Khalid M, Kodeeswaran S, et al
    The prevalence of mental health and addiction concerns and factors associated with depression and anxiety during the COVID-19 pandemic in Ontario, Canada: A cross-sectional study.
    PLoS One. 2024;19:e0305229.
    >> Share

  56. WU Y, Namilae S, Srinivasan A, Mubayi A, et al
    Parametric analysis of SARS-CoV-2 dose-response models in transportation scenarios.
    PLoS One. 2024;19:e0301996.
    >> Share

  57. CHEN F, Nakanishi H, Sekizawa Y, Ochi S, et al
    Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design.
    PLoS One. 2024;19:e0305043.
    >> Share

  58. MOJEBI A, Wu P, Keeping S, Hale B, et al
    Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.
    PLoS One. 2024;19:e0303560.
    >> Share

  59. IBRAHIM MR, Lyons T
    FaceTouch: Detecting hand-to-face touch with supervised contrastive learning to assist in tracing infectious diseases.
    PLoS One. 2024;19:e0288670.
    >> Share

  60. LEE SH, Ten Cate O, Gottlieb M, Horsley T, et al
    The use of virtual nominal groups in healthcare research: An extended scoping review.
    PLoS One. 2024;19:e0302437.
    >> Share

  61. FAIRCLOUGH SJ, Clifford L, Foweather L, Knowles ZR, et al
    Move Well, Feel Good: Feasibility and acceptability of a school-based motor competence intervention to promote positive mental health.
    PLoS One. 2024;19:e0303033.
    >> Share

  62. DALKY A, Quran TO, Abuhammad S, Al-Faraj HM, et al
    COVID-19 vaccine acceptance and associated factors among pregnant and lactating women attending maternity care clinics in refugee camps in Jordan.
    PLoS One. 2024;19:e0305314.
    >> Share

  63. NJUMA LIBWEA J, Esso L, Njoh AA, Ngwa CH, et al
    Generating the evidence to support the establishment of a Respiratory Syncytial Virus surveillance system in Cameroon: A study protocol.
    PLoS One. 2024;19:e0303468.
    >> Share

  64. YUH WT, Kim J, Kim MS, Kim JH, et al
    Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: A national study utilizing the national health insurance database.
    PLoS One. 2024;19:e0305128.
    >> Share

  65. ASHCROFT R, Donnelly C, Sheffield P, Lam S, et al
    A qualitative examination of the experiences and perspectives of interprofessional primary health care teams in the distribution of the COVID-19 vaccination in Ontario, Canada.
    PLoS One. 2024;19:e0304616.
    >> Share

  66. AHMED Z, Gu Y, Sinha K, Mutowo M, et al
    A qualitative exploration of the over-the-counter availability of oral contraceptive pills in Australia.
    PLoS One. 2024;19:e0305085.
    >> Share

  67. CHEONG Q, Kazanjian A, Puyat JH
    Easing anxiety symptoms through leisure activities during social isolation: Findings from nationally representative samples.
    PLoS One. 2024;19:e0303585.
    >> Share

  68. OCHWADA-DOYLE FA, Miles N, Hughes JM, Murphy JJ, et al
    Exploring spatio-temporal changes in coastal recreational fisheries and potential links to extreme weather events.
    PLoS One. 2024;19:e0305106.
    >> Share

  69. CHIEN LC, Marquez ER, Smith S, Tu T, et al
    Exploring the role of the social vulnerability index in understanding COVID-19 immunization rates.
    PLoS One. 2024;19:e0302934.
    >> Share

  70. PENG T, Duong KS, Lu JY, Chacko KR, et al
    Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx.
    PLoS One. 2024;19:e0303151.
    >> Share

  71. FEATHERSTONE AB, Mathijssen AJTM, Brown A, Chitlapilly Dass S, et al
    SARS-CoV-2 Delta variant remains viable in environmental biofilms found in meat packaging plants.
    PLoS One. 2024;19:e0304504.
    >> Share

  72. MCHENGA M, Ndasauka Y, Kondowe F, Kainja J, et al
    Mental health is just an Addendum: Assessing stakeholder's perceptions on COVID-19 and mental health services provision in Malawi.
    PLoS One. 2024;19:e0305341.
    >> Share

  73. CHICOINE N, Schnipper N, Griffin J
    The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
    PLoS One. 2024;19:e0304416.
    >> Share

  74. YANG J, Fang H
    Integrating Embodied Social Presence Theory and Process Virtualization Theory to assess business process virtualizability: The mediating role of embodied co-presence.
    PLoS One. 2024;19:e0305423.
    >> Share

  75. TROTTA E, Serio G, Monacis L, Carlucci L, et al
    The effects of the COVID-19 pandemic on Italian primary school children's learning: A systematic review through a psycho-social lens.
    PLoS One. 2024;19:e0303991.
    >> Share

  76. CHEN LP, Singh-Verdeflor K, Kelly MM, Sklansky DJ, et al
    Disparities in COVID-19 vaccine intentions, testing and trusted sources by household language for children with medical complexity.
    PLoS One. 2024;19:e0305553.
    >> Share

  77. GONZALEZ SUAREZ ML, Mara KC, Rivera CG, Chesdachai S, et al
    Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.
    PLoS One. 2024;19:e0303896.
    >> Share

  78. ETTMAN CK, Cohen GH, Abdalla SM, Hatton CR, et al
    Depression and assets during the COVID-19 pandemic: A longitudinal study of mental health across income and savings groups.
    PLoS One. 2024;19:e0304549.
    >> Share


    Proc Natl Acad Sci U S A

  79. DONKER T, Papathanassopoulos A, Ghosh H, Kociurzynski R, et al
    Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.
    Proc Natl Acad Sci U S A. 2024;121:e2314262121.
    >> Share

  80. AFROZ S, Saul S, Dai J, Surman S, et al
    Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Proc Natl Acad Sci U S A. 2024;121:e2316376121.
    >> Share

  81. MCGOUGH L, Cobey S
    A speed limit on serial strain replacement from original antigenic sin.
    Proc Natl Acad Sci U S A. 2024;121:e2400202121.
    >> Share


    Vaccine

  82. LI J, Gong L, Li J, Gong Z, et al
    Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster.
    Vaccine. 2024;42:3751-3755.
    >> Share

  83. SHANI M, Hermesh I, Feldhamer I, Reges O, et al
    The association between BNT162b2 vaccinations and incidence of immune-mediated comorbidities.
    Vaccine. 2024 May 9:S0264-410X(24)00536-X. doi: 10.1016/j.vaccine.2024.
    >> Share

  84. URQUIDI C, Sepulveda-Penaloza A, Valenzuela MT, Ponce A, et al
    Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs.
    Vaccine. 2024 May 14:S0264-410X(24)00538-3. doi: 10.1016/j.vaccine.2024.
    >> Share

  85. PROSPER P, Rodriguez Puertas R, Guerin DMA, Branda MM, et al
    Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers.
    Vaccine. 2024 May 22:S0264-410X(24)00584-X. doi: 10.1016/j.vaccine.2024.
    >> Share

  86. SOE P, Wong H, Naus M, Muller MP, et al
    mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.
    Vaccine. 2024 May 6:S0264-410X(24)00535-8. doi: 10.1016/j.vaccine.2024.
    >> Share


    Virology

  87. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    >> Share

  88. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
    Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
    Virology. 2024;596:110118.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016